Abstract:ABSTRACT The induction of systemic antibody titers against hemagglutinin has long been the main focus of influenza vaccination strategies, but mucosal immunity has also been shown to play a key role in the protection against respiratory viruses. By vaccinating and challenging healthy volunteers, we demonstrated that inactivated influenza vaccine (IIV) modestly reduced the rate of influenza while predominantly boosting serum antibody titers against hemagglutinin (HA) and HA stalk, a consequence of the low neuraminidase (NA) content of IIV and the intramuscular route of administration. The viral challenge induced nasal and serum responses against both HA and NA. Correlations between mucosal IgA and serum IgG against specific antigens were low, whether before or after challenge, suggesting a compartmentalization of immune responses. Even so, volunteers who developed viral shedding for multiple days had lower baseline titers across both systemic and mucosal compartments as compared to those with no shedding or a single day of shedding. Regression analysis showed that pre-challenge HA inhibition titers were the most consistent correlate of protection across clinical outcomes combining shedding and symptoms, with NA inhibition titers and HA IgG levels only predicting the duration of shedding. Despite the inclusion of data from multiple binding and functional antibody assays against HA and NA performed on both serum and nasal samples, multivariate models were unable to account for the variability in outcomes, emphasizing our imperfect understanding of immune correlates in influenza and the importance of refining models with assessments of innate and cellular immune responses. IMPORTANCE The devastating potential of influenza has been well known for over 100 years. Despite the development of vaccines since the middle of the 20th century, influenza continues to be responsible for substantial global morbidity and mortality. To develop next-generation vaccines with enhanced effectiveness, we must synthesize our understanding of the complex immune mechanisms culminating in protection. Our study outlines the differences in immune responses to influenza vaccine and influenza infection, identifying potential gaps in vaccine-induced immunity, particularly at the level of the nasal mucosa. Furthermore, this research underscores the need to refine our imperfect models while recognizing potential pitfalls in past and future attempts to identify and measure correlates of protection.

Cell-Mediated Proteomics, and Serological and Mucosal Humoral Immune Responses after Seasonal Influenza Immunization: Characterization of Serological Responders and Non-Responders

Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine

Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers

Dynamics of Anti-influenza Mucosal IgA Over a Season in a Cohort of Individuals Living or Working in a Long-term Care Facility

Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

Multiplexed Antibody Sequencing and Profiling of the Human Hemagglutinin-specific Memory B Cell Response following Influenza Vaccination

Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses

Inflammasome Activity in Response to Influenza Vaccination Is Maintained in Monocyte-Derived Peripheral Blood Macrophages in Older Adults

Activated CD4<SUP>+</SUP> T cells and CD14<SUP>hi</SUP>CD16<SUP>+</SUP> monocytes correlate with antibody response following influenza virus infection in humans

Activated Cd4(+) T Cells And Cd14(Hi)Cd16(+) Monocytes Correlate With Antibody Response Following Influenza Virus Infection In Humans

Improved resolution of influenza vaccination responses with high-throughput live virus microneutralisation

Intra-seasonal Antibody Repertoire Analysis of a Subject Immunized with an MF59®-adjuvanted Pandemic 2009 H1N1 Vaccine.

Structural Mapping of Polyclonal IgG Responses to HA After Influenza Virus Vaccination or Infection

Characterisation of specific responses to three models of viral antigens in immunocompetent older adults

Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine

System-Wide Associations between DNA-Methylation, Gene Expression, and Humoral Immune Response to Influenza Vaccination

Immune Response Against Influenza in a Cohort of Repeatedly Vaccinated Adults During the 2017/2018 and 2018/2019 Seasons

Immune Responses to Intradermal and Intramuscular Inactivated Influenza Vaccine among Older Age Group.

Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements.

Similar humoral responses but distinct CD4+ T cell transcriptomic profiles in older adults elicited by MF59 adjuvanted and high dose influenza vaccines